Skip to search formSkip to main contentSkip to account menu

difebarbamate, febarbamate, phenobarbital drug combination

Known as: 2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-bis(2-((aminocarbonyl)oxy)-3-butoxypropyl)-5-ethyl-5-phenyl-, mixt. with 1-(2-((aminocarbonyl)oxy)-3-butoxypropyl)-5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione and 5-ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione, difebarbamate - febarbamate - phenobarbital, tetrabamate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
OBJECTIVES Analysis of all cases of tetrabamate (Atrium)-induced hepatotoxicity reported in the Andalusian Registry of drug… 
2000
2000
Background Tetrabamate (Atrium®), widely used in the treatment of tremor and ethanol‐withdrawal symptoms, has been incriminated… 
1995
1995
  • P. Batel
  • Drug and alcohol dependence
  • 1995
  • Corpus ID: 28041417
1995
1995
Tetrabamate (Atrium), a composite preparation of phenobarbital, difebarbamate and febarbamate, is widely used to reduce ethanol… 
1993
1993
Acute alcohol ingestion can lead to psychiatric emergencies. The main syndromes observed are states of agitation, acute anxiety… 
1991
1991
The anxiolytic efficacy of tetrabamate was evaluated in a multicentric double-blind study versus lorazepam and placebo, in 269…